Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
about
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@ast
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@en
type
label
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@ast
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@en
prefLabel
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@ast
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@en
P2093
P2860
P1476
Efficacy and safety of neoadju ...... rectal cancer: the FACT trial.
@en
P2093
Hajime Yokomizo
Hayato Kan
Hideyuki Ishida
Hirotoshi Hasegawa
Hiroyuki Shiokawa
Junichi Koike
Kazuhiko Yoshimatsu
Kazuhiro Sakamoto
Keiichiro Ishibashi
Keiji Koda
P2860
P2888
P304
P356
10.1007/S00280-017-3243-7
P577
2017-02-01T00:00:00Z
P6179
1083403980